DAVENPORT & Co LLC decreased its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.
The boss of drugmaker AstraZeneca has said he was “very disappointed” with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, but insisted the business case did not stack up ...
In early UK corporate news, AstraZeneca reported earnings growth, Compass backed its outlook and Babcock raised its expectations. Elsewhere, BBGI Global Infrastructure backed a takeover offer. Here is ...
This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...
In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative treatments, and holistic patient care under this year’s theme, “United by Unique.
Cancer remains one of the leading causes of death globally, with delayed diagnoses and limited access to advanced care significantly contributing to poor outcomes.
AstraZeneca, MasterCard, Dow Jones and more DUBAI, UAE, Feb. 4, 2025 /CNW/ -- In an era where governance, technology, and economic resilience define the future of nations, the World Governments Summit ...
If you purchased or acquired securities in AstraZeneca between between February 23, 2022 and December 17, 2024 and would like ...
LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...
The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine ... pressure" after an email emerged ...